Advertisement

In Vivo Assessment of NK Cell-Mediated Cytotoxicity by Adoptively Transferred Splenocyte Rejection

  • Nathan J. Schloemer
  • Alex M. Abel
  • Monica S. Thakar
  • Subramaniam MalarkannanEmail author
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 2097)

Abstract

NK cells are innate lymphocytes that are vital to clearance of virally infected or malignantly transformed cells. Assessment of the cytotoxic response is an important component of NK cell research and investigation of human disease. Standard assays of NK cell-mediated cytotoxicity of CD107a degranulation or 51Cr release assay utilize cultured or freshly isolated NK cell populations in vitro. In addition to requirements to maintain multiple target cell lines and radioactivity precautions in the case of 51Cr, these are in vitro evaluations of a complex in vivo function. Here, we describe the in vivo assessment of NK cell-mediated cytotoxicity through the adoptive transfer of splenocytes and their subsequent rejection. This protocol offers rapid, quantitative, and concurrent assessment of NK cell-mediated cytotoxicity against the prototypic NK stimulations of “missing-self” and “nonself.”

Keywords

NK cell Cytotoxicity Transplant Missing-self Nonself In vivo 

Notes

Acknowledgements

Funding Support: We thank Lucia Sammarco and her Lulu’s Lemonade Stand for inspiration, motivation, and support. This work was supported in part by Ann’s Hope Melanoma Foundation (S.M. and M.S.T.); NIH R01 AI102893 (S.M.) and NCI R01 CA179363 (S.M. and M.S.T.); Alex Lemonade Stand Foundation (N.J.S); HRHM Program of MACC Fund/Children’s Hospital of Wisconsin (S.M.), Nicholas Family Foundation (S.M.); Gardetto Family (S.M.); MCW-Cancer Center-Large Seed Grant (S.M. & M.S.T.); and MACC Fund/Children’s Hospital of Wisconsin (M.S.T. and S.M.).

References

  1. 1.
    Abel AM, Yang C, Thakar MS, Malarkannan S (2018) Natural killer cells: development, maturation, and clinical utilization. Front Immunol 9:1869.  https://doi.org/10.3389/fimmu.2018.01869CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S (2008) Functions of natural killer cells. Nat Immunol 9(5):503–510.  https://doi.org/10.1038/ni1582CrossRefPubMedGoogle Scholar
  3. 3.
    Rajasekaran K, Kumar P, Schuldt KM, Peterson EJ, Vanhaesebroeck B, Dixit V, Thakar MS, Malarkannan S (2013) Signaling by Fyn-ADAP via the Carma1-Bcl-10-MAP3K7 signalosome exclusively regulates inflammatory cytokine production in NK cells. Nat Immunol 14(11):1127–1136.  https://doi.org/10.1038/ni.2708CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Alter G, Malenfant JM, Altfeld M (2004) CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods 294(1-2):15–22.  https://doi.org/10.1016/j.jim.2004.08.008CrossRefPubMedGoogle Scholar
  5. 5.
    Brunner KT, Mauel J, Cerottini JC, Chapuis B (1968) Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs. Immunology 14(2):181–196PubMedPubMedCentralGoogle Scholar
  6. 6.
    Hsu HT, Mace EM, Carisey AF, Viswanath DI, Christakou AE, Wiklund M, Onfelt B, Orange JS (2016) NK cells converge lytic granules to promote cytotoxicity and prevent bystander killing. J Cell Biol 215(6):875–889.  https://doi.org/10.1083/jcb.201604136CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Korzeniewski C, Callewaert DM (1983) An enzyme-release assay for natural cytotoxicity. J Immunol Methods 64(3):313–320CrossRefGoogle Scholar
  8. 8.
    Wang M, Ellison CA, Gartner JG, HayGlass KT (1998) Natural killer cell depletion fails to influence initial CD4 T cell commitment in vivo in exogenous antigen-stimulated cytokine and antibody responses. J Immunol 160(3):1098–1105Google Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2020

Authors and Affiliations

  • Nathan J. Schloemer
    • 1
    • 2
  • Alex M. Abel
    • 1
    • 2
    • 3
  • Monica S. Thakar
    • 1
    • 2
  • Subramaniam Malarkannan
    • 1
    • 2
    • 3
    • 4
    Email author
  1. 1.Laboratory of Molecular Immunology and Immunotherapy, Blood Research InstituteBlood Center of WisconsinMilwaukeeUSA
  2. 2.Department of PediatricsMedical College of WisconsinMilwaukeeUSA
  3. 3.Department of Microbiology and ImmunologyMedical College of WisconsinMilwaukeeUSA
  4. 4.Department of MedicineMedical College of WisconsinMilwaukeeUSA

Personalised recommendations